Genetics Generation Advancement Corp.

TPEX:4160 Stock Report

Market Cap: NT$1.8b

Genetics Generation Advancement Past Earnings Performance

Past criteria checks 5/6

Genetics Generation Advancement has been growing earnings at an average annual rate of 45%, while the Biotechs industry saw earnings growing at 21.4% annually. Revenues have been growing at an average rate of 8.9% per year. Genetics Generation Advancement's return on equity is 10.2%, and it has net margins of 8.8%.

Key information

45.0%

Earnings growth rate

45.0%

EPS growth rate

Biotechs Industry Growth12.2%
Revenue growth rate8.9%
Return on equity10.2%
Net Margin8.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Feb 25
Consider This Before Buying Genetics Generation Advancement Corp. (GTSM:4160) For The 2.8% Dividend

Revenue & Expenses Breakdown

How Genetics Generation Advancement makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:4160 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246645816958
30 Jun 246494417158
31 Mar 246253516855
31 Dec 235932916454
30 Sep 235762816254
30 Jun 235543115752
31 Mar 235432215552
31 Dec 225482615452
30 Sep 225281815054
30 Jun 225321414755
31 Mar 225391914856
31 Dec 21520814951
30 Sep 21513014745
30 Jun 21495-814339
31 Mar 21457-1613733
31 Dec 20443-1613132
30 Sep 20441-513134
30 Jun 20426-112934
31 Mar 204391013033
31 Dec 194291812730
30 Sep 194242012524
30 Jun 194082112321
31 Mar 193851611820
31 Dec 183821711720
30 Sep 183721410724
30 Jun 183731710422
31 Mar 18369149920
31 Dec 17366119420
30 Sep 1735249316
30 Jun 1736828915
31 Mar 17360-28815
31 Dec 16346-88814
30 Sep 16333-118515
30 Jun 16297-168216
31 Mar 16299-97719
31 Dec 15275-137622
30 Sep 15262-367624
30 Jun 15225-407524
31 Mar 15214-477624
31 Dec 14222-427222
30 Sep 14236-157420
30 Jun 14259-177219
31 Mar 14243-227218

Quality Earnings: 4160 has high quality earnings.

Growing Profit Margin: 4160's current net profit margins (8.8%) are higher than last year (4.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4160's earnings have grown significantly by 45% per year over the past 5 years.

Accelerating Growth: 4160's earnings growth over the past year (109%) exceeds its 5-year average (45% per year).

Earnings vs Industry: 4160 earnings growth over the past year (109%) exceeded the Biotechs industry 8.8%.

Return on Equity

High ROE: 4160's Return on Equity (10.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 20:52
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genetics Generation Advancement Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.